Adenoviral vector carrying glial cell-derived neurotrophic factor for direct gene therapy in comparison with human umbilical cord blood cell-mediated therapy of spinal cord injury in rat

Spinal Cord

Volumn 54, Issue 5, 2016, Pages 347-359

  Mukhamedshina, Y O ^a   Shaymardanova, G F ^b   Garanina, ^a   Salafutdinov, I I ^a   Rizvanov, ^a   Islamov, R R ^c   Chelyshev, Y A ^c  

^a KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^b KAZAN INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Russian Federation)

^c KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; AQUAPORIN 4; CONNEXIN 47; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN S100B; ENHANCED GREEN FLUORESCENT PROTEIN; GAP JUNCTION PROTEIN; GDNF PROTEIN, HUMAN; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; MYELIN PROTEIN; NERVE PROTEIN; S100B PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL MIGRATION; CELL POPULATION; CELL SURVIVAL; CELL THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL STUDY; GENE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LOCOMOTION; MONONUCLEAR CELL; MORPHOMETRICS; MYELINATED NERVE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; RUSSIAN FEDERATION; SCHWANN CELL; SPINAL CORD INJURY; UMBILICAL CORD BLOOD; ANIMAL; BIOLOGICAL THERAPY; CONVALESCENCE; DISEASE MODEL; FEMALE; GENE TRANSFER; GENE VECTOR; GENETICS; HEK293 CELL LINE; MALE; METABOLISM; NONPARAMETRIC TEST; PHYSIOLOGY; PROCEDURES; SPINAL CORD INJURIES;

ANIMALS; AQUAPORIN 4; CELL- AND TISSUE-BASED THERAPY; CONNEXINS; DISEASE MODELS, ANIMAL; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; LOCOMOTION; MALE; MYELIN P0 PROTEIN; NERVE TISSUE PROTEINS; RATS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECOVERY OF FUNCTION; RNA, MESSENGER; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SPINAL CORD INJURIES; STATISTICS, NONPARAMETRIC;

EID: 84942543814     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2015.161     Document Type: Article

References (36)

1. Airaksinen MS, Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 2002; 3: 383-394.
2. Tansey MG, Baloh RH, Milbrandt J, Johnson Jr. E.M. GFRalpha-mediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival. Neuron 2000; 25: 611-623.
3. Encinas M, Tansey MG, Tsui-Pierchala BA, Comella JX, Milbrandt J, Johnson Jr. E.M. c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligandmediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3 K)-dependent pathway. J Neurosci 2001; 21: 1464-1472.
4. Cheng H, Wu JP, Tzeng SF. Neuroprotection of glial cell line-derived neurotrophic factor in damaged spinal cords following contusive injury. J Neurosci Res 2002; 69: 397-405.
5. Iannotti C, Li H, Yan P, Lu X, Wirthlin L, Xu XM. Glial cell line-derived neurotrophic factor-enriched bridging transplants promote propriospinal axonal regeneration and enhance myelination after spinal cord injury. Exp Neurol 2003; 183: 379-393.
6. Barati S, Hurtado PR, Zhang SH, Tinsley R, Ferguson IA, Rush RA. GDNF gene delivery via the p75(NTR) receptor rescues injured motor neurons. Exp Neurol 2006; 202: 179-188.
7. Mills CD, Allchorne AJ, Griffin RS, Woolf CJ, Costigan M. GDNF selectively promotes regeneration of injury-primed sensory neurons in the lesioned spinal cord. Mol Cell Neurosci 2007; 36: 185-194.
8. Storer PD, Dolbeare D, Houle JD. Treatment of chronically injured spinal cord with neurotrophic factors stimulates betaII-Tubulin and GAP-43 expression in rubrospinal tract neurons. J Neurosci Res 2003; 74: 502-511.
9. Lu KW, Chen ZY, Jin DD, Hou TS, Cao L, Fu Q. Cationic liposome-mediated GDNF gene transfer after spinal cord injury. J Neurotrauma 2002; 19: 1081-1090.
10. Sakurai M, Abe K, Hayashi T, Setoguchi Y, Yaginuma G, Meguro T, et al. Adenovirusmediated glial cell line-derived neurotrophic factor gene delivery reduces motor neuron injury after transient spinal cord ischemia in rabbits. J Thorac Cardiovasc Surg 2000; 120: 1148-1157.
11. Koelsch A, Feng Y, Fink DJ, Mata M. Transgene-mediated GDNF expression enhances synaptic connectivity and GABA transmission to improve functional outcome after spinal cord contusion. J Neurochem 2010; 113: 143-152.
12. Tai MH, Cheng H, Wu JP, Liu YL, Lin PR, Kuo JS, et al. Gene transfer of glial cell linederived neurotrophic factor promotes functional recovery following spinal cord contusion. Exp Neurol 2003; 183: 508-515.
13. Tang XQ, Wang Y, Huang ZH, Han JS, Wan Y. Adenovirus-mediated delivery of GDNF ameliorates corticospinal neuronal atrophy and motor function deficits in rats with spinal cord injury. Neuroreport 2004; 15: 425-429.
14. Blesch A, Tuszynski MH. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination. J Comp Neurol 2003; 467: 403-417.
15. Yan HB, Zhang ZM, Jin DD, Wang XJ, Lu KW. The repair of acute spinal cord injury in rats by olfactory ensheathing cells graft modified by glia cell line-derived neurotrophic factor gene in combination with the injection of monoclonal antibody IN-1. Zhonghua Wai Ke Za Zhi 2009; 47: 1817-1820.
16. Deng XY, Zhou RP, Lu KW, Jin DD. Lithium chloride combined with human umbilical cord blood mesenchymal stem cell transplantation for treatment of spinal cord injury in rats. Nan Fang Yi Ke Da Xue Xue Bao 2010; 30: 2436-2439.
17. Park DH, Lee JH, Borlongan CV, Sanberg PR, Chung YG, Cho TH. Transplantation of umbilical cord blood stem cells for treating spinal cord injury. Stem Cell Rev 2011; 7: 181-194.
18. Han ZX, Shi Q, Wang DK, Li D, Lyu M. Basic biological characteristics of mesenchymal stem cells derived from bone marrow and human umbilical cord. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2013; 21: 1248-1255.
19. Rizvanov AA, Kiyasov AP, Gaziziov IM, Yilmaz TS, Kaligin MS, Andreeva DI, et al. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-Trophic factors to support neurogenesisa novel approach in stem cell therapy. Neurochem Int 2008; 53: 389-394.
20. Rizvanov AA, Guseva DS, Salafutdinov II, Kudryashova NV, Bashirov FV, Kiyasov AP, et al. Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice. Exp Biol Med (Maywood) 2011; 236: 91-98.
21. Islamov RR, Rizvanov AA, Mukhamedyarov MA, Salafutdinov II, Garanina EE, Fedotova VY, et al. Symptomatic improvement, increased life-span and sustained cell homing in amyotrophic lateral sclerosis after transplantation of human umbilical cord blood cells genetically modified with adeno-viral vectors expressing a neuroprotective factor and a neural cell adhesion molecule. Curr Gene Ther 2015; 15: 266-276.
22. Lebedev SV, Timofeyev SV, Zharkov AV, Schipilov VG, Chelyshev JA, Masgutova GA, et al. Exercise tests and BBB method for evaluation of motor disorders in rats after contusion spinal injury. Bull Exp Biol Med 2008; 146: 489-494.
23. Watzlawik JO, Warrington AE, Rodriguez M. PDGF is required for remyelinationpromoting IgM stimulation of oligodendrocyte progenitor cell proliferation. PLoS One 2013; 8: e55149.
24. Odermatt B, Wellershaus K, Wallraff A, Seifert G, Degen J, Euwens C, et al. Connexin 47 (Cx47)-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of Cx47 and display vacuolized myelin in the CNS. J Neurosci 2003; 23: 4549-4559.
25. Korbling M, Robinson S, Estrov Z, Champlin R, Shpall E. Umbilical cord blood-derived cells for tissue repair. Cytotherapy 2005; 7: 258-261.
26. Guseva D, Rizvanov AA, Salafutdinov II, Kudryashova NV, Palotas A, Islamov RR. Overexpression of Oct4 and Sox2 transcription factors enhances differentiation of human umbilical cord blood cells in vivo. Biochem Biophys Res Commun 2014; 451: 503-509.
27. Liu G, Wang X, Shao G, Liu Q. Genetically modified Schwann cells producing glial cell line-derived neurotrophic factor inhibit neuronal apoptosis in rat spinal cord injury. Mol Med Rep 2014; 9: 1305-1312.
28. Lu KW, Chen ZY, Hou TS. Protective effect of liposome-mediated glial cell line-derived neurotrophic factor gene transfer in vivo on motoneurons following spinal cord injury in rats. Chin J Traumatol 2004; 7: 275-279.
29. Scherer SS, Chance PF. Myelin genes: getting the dosage right. Nat Genet 1995; 11: 226-228.
30. Jasmin L, Janni G, Moallem TM, Lappi DA, Ohara PT. Schwann cells are removed from the spinal cord after effecting recovery from paraplegia. J Neurosci 2000; 20: 9215-9223.
31. Mukhamedshina YO, Shaymardanova GF, Muhitov AR, Salafutdinov II, Rizvanov AA, Zarubina VN, et al. Survival and differentiation of endogenous Schwann cells migrating into spinal cord under the influence of neurotrophic factors. Cell Transplant Tissue Eng 2012; 7: 125-129.
32. Iwase T, Jung CG, Bae H, Zhang M, Soliven B. Glial cell line-derived neurotrophic factor-induced signaling in Schwann cells. J Neurochem 2005; 94: 1488-1499.
33. Jesuraj NJ, Marquardt LM, Kwasa JA, Sakiyama-Elbert SE. Glial cell line-derived neurotrophic factor promotes increased phenotypic marker expression in femoral sensory and motor-derived Schwann cell cultures. Exp Neurol 2014; 257: 10-18.
34. Zhang L, Ma Z, Smith GM, Wen X, Pressman Y, Wood PM, et al. GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons. Glia 2009; 57: 1178-1191.
35. Suen Y, Lee SM, Schreurs J, Knoppel E, Cairo MS. Decreased macrophage colony-stimulating factor mRNA expression from activated cord versus adult mononuclear cells: altered post-Transcriptional stability. Blood 1994; 84: 4269-4277.
36. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004; 114: 330-338.